LUIS JAVIER
GARCIA FRADE
Investigador en el periodo 1993-2023
![Foto de LUIS JAVIER](/img/nophoto.png)
![Foto de Hospital Universitario Pío del Río Hortega](/img/noimage_org.png)
Hospital Universitario Pío del Río Hortega
Valladolid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Pío del Río Hortega (43)
2024
-
A post hoc comparative real-world analysis of HEAD-US score for joint health assessment of patients with severe haemophilia A and B in Spain
Haemophilia, Vol. 30, Núm. 2, pp. 513-522
2023
-
Comparative analysis of Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) scores in persons with nonsevere hemophilia A and B reveals a high degree of joint damage in both disease types
Research and Practice in Thrombosis and Haemostasis
2021
-
Autologous serum eye drops improve tear production, both lachrymal flow and stability tests and conjunctival impression cytology with transfer in dry eye disease
Blood Transfusion, Vol. 19, Núm. 1, pp. 45-53
2020
-
Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diary
Haemophilia, Vol. 26, Núm. 6, pp. 999-1008
-
Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia
European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270
2019
-
Joint status in Spanish haemophilia B patients assessed using the Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) score
Haemophilia, Vol. 25, Núm. 1, pp. 144-153
2018
-
Polymorphisms in receptors involved in opsonic and nonopsonic phagocytosis, and correlation with risk of infection in oncohematology patients
Infection and Immunity, Vol. 86, Núm. 12
-
Role of multimeric analysis of von willebrand factor (VWF) in von willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project
PLoS ONE, Vol. 13, Núm. 6
2017
-
Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes
Thrombosis and Haemostasis, Vol. 117, Núm. 1, pp. 66-74
-
Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice
International Journal of Hematology, Vol. 106, Núm. 4, pp. 508-516
-
Molecular and clinical profile of von willebrand disease in Spain (PCM-EVW-ES): Comprehensive genetic analysis by next-generation sequencing of 480 patients
Haematologica, Vol. 102, Núm. 12, pp. 2005-2014
-
Use of eltrombopag for secondary immune thrombocytopenia in clinical practice
British Journal of Haematology, Vol. 178, Núm. 6, pp. 959-970
2016
-
Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial
Annals of Hematology, Vol. 95, Núm. 6, pp. 893-899
-
Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders
Haemophilia, Vol. 22, Núm. 4, pp. 590-597
-
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
European Journal of Haematology, Vol. 97, Núm. 3, pp. 297-302
-
Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients
Acta Haematologica, Vol. 136, Núm. 2, pp. 76-84
-
Molecular and clinical profile of von willebrand disease in spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm
Thrombosis and Haemostasis, Vol. 115, Núm. 1, pp. 40-50
-
Pharmacological inhibition of eicosanoids and platelet-activating factor signaling impairs zymosan-induced release of IL-23 by dendritic cells
Biochemical Pharmacology, Vol. 102, pp. 78-96
2015
-
Enfermedad de Gaucher
Anales de la Real Academia de Medicina y Cirugía de Valladolid, Núm. 52, pp. 125-142
-
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
American Journal of Hematology, Vol. 90, Núm. 3, pp. E40-E43